Abstract
InstructionsTo obtain continuing education credit:1.Read the article carefully.2.Read each question and determine the correct answer.3.Visit PedsCESM, ce.napnap.org, to complete the online Posttest and evaluation.4.You must receive 70% correct responses to receive the certificate.5.Tests will be accepted until April 30, 2019.ObjectivesAt the conclusion of this activity, learners should be better able to:1.Summarize the role of skin barrier dysfunction and inflammatory pathways and responses in AD pathogenesis.2.Identify management strategies for mild to moderate AD based on patient and caregiver preferences, adherence, and concerns.3.Describe the efficacy and safety of currently available therapies and their potential role in the management of mild to moderate AD.4.Implement into practice shared decision-making strategies to increase patient and caregiver involvement in AD management.Contact hours: 1.0Passing score: 70%This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the Posttest will be awarded 1.0 NAPNAP contact hour of which 0.5 is pharmacology.Earn FREE CE Contact Hours OnlineContact Hours for this online activity are FREE for NAPNAP Members.1.To take the Posttest for this article and earn contact hours, please go to PedsCESM at ce.napnap.org.2.In the Course Catalog, search for the name of the CE article.3.If you already have an account with PedsCESM, log in using your username and password. If you are a NAPNAP member, log in with your username and password. If you are a first-time user and NAPNAP non-member, click on “New Customer? Click Here.”4.Once you have successfully passed the Posttest and completed the evaluation form, you will be able to print out your certificate immediately.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.